نتایج جستجو برای: medulloblastoma radiotherapy

تعداد نتایج: 67113  

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2012
Michiel Smits Sjoerd van Rijn Esther Hulleman Dennis Biesmans Dannis G van Vuurden Marcel Kool Christine Haberler Eleonora Aronica W Peter Vandertop David P Noske Thomas Würdinger

PURPOSE Medulloblastoma is the most common malignant brain tumor in children. Despite recent improvements, the molecular mechanisms driving medulloblastoma are not fully understood and further elucidation could provide cues to improve outcome prediction and therapeutic approaches. EXPERIMENTAL DESIGN Here, we conducted a meta-analysis of mouse and human medulloblastoma gene expression data se...

2013
Kristian W Pajtler Christina Weingarten Theresa Thor Annette Künkele Lukas C Heukamp Reinhard Büttner Takayoshi Suzuki Naoki Miyata Michael Grotzer Anja Rieb Annika Sprüssel Angelika Eggert Alexander Schramm Johannes H Schulte

BACKGROUND Medulloblastoma is a leading cause of childhood cancer-related deaths. Current aggressive treatments frequently lead to cognitive and neurological disabilities in survivors. Novel targeted therapies are required to improve outcome in high-risk medulloblastoma patients and quality of life of survivors. Targeting enzymes controlling epigenetic alterations is a promising approach recent...

2016
Matthew N. Svalina Ken Kikuchi Jinu Abraham Sangeet Lal Monika A. Davare Teagan P. Settelmeyer Michael C. Young Jennifer L. Peckham Yoon-Jae Cho Joel E. Michalek Brian S. Hernandez Noah E. Berlow Melanie Jackson Daniel J. Guillaume Nathan R. Selden Darell D. Bigner Kellie J. Nazemi Sarah C. Green Christopher L. Corless Sakir Gultekin Atiya Mansoor Brian P. Rubin Randall Woltjer Charles Keller

Risk or presence of metastasis in medulloblastoma causes substantial treatment-related morbidity and overall mortality. Through the comparison of cytokines and growth factors in the cerebrospinal fluid (CSF) of metastatic medulloblastoma patients with factors also in conditioned media of metastatic MYC amplified medulloblastoma or leptomeningeal cells, we were led to explore the bioactivity of ...

2012
Rebecca M Howell Annelise Giebeler Wendi Koontz-Raisig Anita Mahajan Carol J Etzel Anthony M D’Amelio Kenneth L Homann Wayne D Newhauser

BACKGROUND For many decades, the standard of care radiotherapy regimen for medulloblastoma has been photon (megavoltage x-rays) craniospinal irradiation (CSI). The late effects associated with CSI are well-documented in the literature and are in-part attributed to unwanted dose to healthy tissue. Recently, there is growing interest in using proton therapy for CSI in pediatric and adolescent pat...

2011
Alp ozgun BorcEk Emre DurDAG Hakan EMMEz Gokhan kurT M. kemali BAykANEr

Medulloblastoma is the most common malignant tumor of childhood and usually arises from the cerebellar vermis. Several histological types of medulloblastoma have been described. Myogenic and melanotic differentiated medulloblastoma are seldom seen. We present a case diagnosed as myogenic medulloblastoma with focal areas of melanotic differentiation. A 4-year-old boy was admitted due to headache...

Journal: :Neuro-oncology 2009
Hirokatsu Osawa Christian A Smith Young Shin Ra Paul Kongkham James T Rutka

Medulloblastoma is a highly malignant brain tumor that occurs predominantly in children. The molecular pathogenesis of medulloblastoma is under investigation. Previously, we used complementary DNA microarray analysis to compare patterns of gene expression in medulloblastoma samples versus normal cerebellum. The cytoskeletal protein ezrin was found to be overexpressed in medulloblastoma compared...

2014
Cornelia M. Hooper Susan M. Hawes Ursula R. Kees Nicholas G. Gottardo Peter B. Dallas

Medulloblastoma is the most common form of malignant paediatric brain tumour and is the leading cause of childhood cancer related mortality. The four molecular subgroups of medulloblastoma that have been identified - WNT, SHH, Group 3 and Group 4 - have molecular and topographical characteristics suggestive of different cells of origin. Definitive identification of the cell(s) of origin of the ...

2011
Manish Singh Goutham Cugati Nigel Peter Symss Anil Pande Madabushi Chakravarthy Vasudevan Ravi Ramamurthi

A 22-year-old male patient presented with headache, vomiting, ataxia, and left facial weakness of one-month duration. Vision was normal. Fundus examination showed papilloedema. He had left lower motor neuron facial paresis, left IX and X cranial nerve paresis, and left cerebellar signs. Computed tomography scan of the brain showed a left CP angle mixed-density nonenhancing lesion (5.4 × 2.8 cm)...

Journal: :The Laryngoscope 2010
J Thomas Roland Maura Cosetti Tracey Liebman Susan Waltzman Jeffrey C Allen

OBJECTIVES/HYPOTHESIS Medulloblastoma is the most common pediatric malignant tumor of the central nervous system in children. Treatment includes surgical excision, external beam radiation, and multiagent chemotherapy. Otologic sequelae are common and may result from radiation and/or chemotherapy. Profound sensorineural hearing loss (SNHL) is a known complication of neuro-oncologic treatment and...

Journal: :Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008
Maryam Fouladi Murali Chintagumpala David Ashley Stewart Kellie Sridharan Gururangan Tim Hassall Lindsey Gronewold Clinton F Stewart Dana Wallace Alberto Broniscer Gregory A Hale Kimberly A Kasow Thomas E Merchant Brannon Morris Matthew Krasin Larry E Kun James M Boyett Amar Gajjar

PURPOSE To determine the role of amifostine as a protectant against cisplatin-induced ototoxicity in patients with average-risk (AR) medulloblastoma treated with craniospinal radiotherapy and four cycles of cisplatin-based, dose-intense chemotherapy and stem-cell rescue. PATIENTS AND METHODS The primary objective was to determine whether, in patients with AR medulloblastoma (n = 62), amifosti...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید